Maribavir for treatment of cytomegalovirus infections resistant or refractory to ganciclovir or foscarnet in hematopoietic stem cell transplant or solid organ transplant recipients: A randomized, dose-ranging, double-blind, phase 2 study Meeting Abstract
| Authors: | Papanicolaou, G. A.; Silveira, F. P.; Langston, A. A.; Pereira, M. R.; Avery, R. K.; Wijatyk, A.; Wu, J. J.; Boeckh, M. J.; Marty, F. M.; Villano, S. |
| Abstract Title: | Maribavir for treatment of cytomegalovirus infections resistant or refractory to ganciclovir or foscarnet in hematopoietic stem cell transplant or solid organ transplant recipients: A randomized, dose-ranging, double-blind, phase 2 study |
| Meeting Title: | 2017 BTM Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 23 |
| Issue: | 3 Suppl. 1 |
| Meeting Dates: | 2017 Feb 22-26 |
| Meeting Location: | Orlando, FL |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-03-01 |
| Start Page: | S51 |
| End Page: | S52 |
| Language: | English |
| ACCESSION: | WOS:000540635000043 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2017.01.061 |
| Notes: | Meeting Abstract: 45; The page number on ScienceDirect is erroneously listed as S56-S57 -- Source: Wos |
